25 participants
Phase IIa Clinical Study of N-Rephasin® SAL200
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-06
- Start Date:
- 2017-03-07
- Completion:
- 2019-11-07
Conditions
- Staphylococcus Aureus Bacteremia
- Anti-Bacterial Agents
Interventions
- BIOLOGICAL
- OTHER